These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
713 related articles for article (PubMed ID: 29991871)
1. Role of microRNAs in the main molecular pathways of hepatocellular carcinoma. Vasuri F; Visani M; Acquaviva G; Brand T; Fiorentino M; Pession A; Tallini G; D'Errico A; de Biase D World J Gastroenterol; 2018 Jul; 24(25):2647-2660. PubMed ID: 29991871 [TBL] [Abstract][Full Text] [Related]
2. Comprehensive analysis of microRNA-regulated protein interaction network reveals the tumor suppressive role of microRNA-149 in human hepatocellular carcinoma via targeting AKT-mTOR pathway. Zhang Y; Guo X; Xiong L; Yu L; Li Z; Guo Q; Li Z; Li B; Lin N Mol Cancer; 2014 Nov; 13():253. PubMed ID: 25424347 [TBL] [Abstract][Full Text] [Related]
3. Circulating microRNAs as diagnostic and prognostic tools for hepatocellular carcinoma. Zhang YC; Xu Z; Zhang TF; Wang YL World J Gastroenterol; 2015 Sep; 21(34):9853-62. PubMed ID: 26379392 [TBL] [Abstract][Full Text] [Related]
4. Analysis of clinical significance and prospective molecular mechanism of main elements of the JAK/STAT pathway in hepatocellular carcinoma. Wang X; Liao X; Yu T; Gong Y; Zhang L; Huang J; Yang C; Han C; Yu L; Zhu G; Qin W; Liu Z; Zhou X; Liu J; Han Q; Peng T Int J Oncol; 2019 Oct; 55(4):805-822. PubMed ID: 31485610 [TBL] [Abstract][Full Text] [Related]
5. Biomarkers Associated With Response to Regorafenib in Patients With Hepatocellular Carcinoma. Teufel M; Seidel H; Köchert K; Meinhardt G; Finn RS; Llovet JM; Bruix J Gastroenterology; 2019 May; 156(6):1731-1741. PubMed ID: 30738047 [TBL] [Abstract][Full Text] [Related]
6. The Role of Long Non-Coding RNA and microRNA Networks in Hepatocellular Carcinoma and Its Tumor Microenvironment. Shi T; Morishita A; Kobara H; Masaki T Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638971 [TBL] [Abstract][Full Text] [Related]
7. Overexpression of microRNA-133b is associated with the increased survival of patients with hepatocellular carcinoma after curative hepatectomy: Involvement of the EGFR/PI3K/Akt/mTOR signaling pathway. Wang X; Zeng J; Wang L; Zhang X; Liu Z; Zhang H; Dong J Oncol Rep; 2017 Jul; 38(1):141-150. PubMed ID: 28586051 [TBL] [Abstract][Full Text] [Related]
8. microRNA-539 suppresses tumor growth and tumorigenesis and overcomes arsenic trioxide resistance in hepatocellular carcinoma. Zhu C; Zhou R; Zhou Q; Chang Y; Jiang M Life Sci; 2016 Dec; 166():34-40. PubMed ID: 27717846 [TBL] [Abstract][Full Text] [Related]
9. MicroRNAs involved with hepatocellular carcinoma (Review). Mao B; Wang G Oncol Rep; 2015 Dec; 34(6):2811-20. PubMed ID: 26398882 [TBL] [Abstract][Full Text] [Related]
10. Hepatic miR-126 is a potential plasma biomarker for detection of hepatitis B virus infected hepatocellular carcinoma. Ghosh A; Ghosh A; Datta S; Dasgupta D; Das S; Ray S; Gupta S; Datta S; Chowdhury A; Chatterjee R; Mohapatra SK; Banerjee S Int J Cancer; 2016 Jun; 138(11):2732-44. PubMed ID: 26756996 [TBL] [Abstract][Full Text] [Related]
11. Cancer-related microRNAs and their role as tumor suppressors and oncogenes in hepatocellular carcinoma. Gailhouste L; Ochiya T Histol Histopathol; 2013 Apr; 28(4):437-51. PubMed ID: 23224781 [TBL] [Abstract][Full Text] [Related]
12. Role of MicroRNA in the Diagnosis and Management of Hepatocellular Carcinoma. Ziogas IA; Sioutas G; Mylonas KS; Tsoulfas G Microrna; 2020; 9(1):25-40. PubMed ID: 31218966 [TBL] [Abstract][Full Text] [Related]
13. Significance of serum microRNA-21 in diagnosis of hepatocellular carcinoma (HCC): clinical analyses of patients and an HCC rat model. Wang X; Zhang J; Zhou L; Lu P; Zheng ZG; Sun W; Wang JL; Yang XS; Li XL; Xia N; Zhang N; Dou KF Int J Clin Exp Pathol; 2015; 8(2):1466-78. PubMed ID: 25973032 [TBL] [Abstract][Full Text] [Related]
14. Co-targeting of IGF1R/mTOR pathway by miR-497 and miR-99a impairs hepatocellular carcinoma development. Cheng H; Xue J; Yang S; Chen Y; Wang Y; Zhu Y; Wang X; Kuang D; Ruan Q; Duan Y; Wang G Oncotarget; 2017 Jul; 8(29):47984-47997. PubMed ID: 28624790 [TBL] [Abstract][Full Text] [Related]
15. Role of regulatory miRNAs of the PI3K/AKT/mTOR signaling in the pathogenesis of hepatocellular carcinoma. Rahmani F; Ziaeemehr A; Shahidsales S; Gharib M; Khazaei M; Ferns GA; Ryzhikov M; Avan A; Hassanian SM J Cell Physiol; 2020 May; 235(5):4146-4152. PubMed ID: 31663122 [TBL] [Abstract][Full Text] [Related]
16. Early-phase circulating miRNAs predict tumor recurrence and survival of hepatocellular carcinoma patients after liver transplantation. Ng KT; Lo CM; Wong N; Li CX; Qi X; Liu XB; Geng W; Yeung OW; Ma YY; Chan SC; Man K Oncotarget; 2016 Apr; 7(15):19824-39. PubMed ID: 26918346 [TBL] [Abstract][Full Text] [Related]
17. Novel serum microRNAs panel on the diagnostic and prognostic implications of hepatocellular carcinoma. An Y; Gao S; Zhao WC; Qiu BA; Xia NX; Zhang PJ; Fan ZP World J Gastroenterol; 2018 Jun; 24(24):2596-2604. PubMed ID: 29962816 [TBL] [Abstract][Full Text] [Related]
18. Serum/plasma microRNAs as biomarkers for HBV-related hepatocellular carcinoma in China. Yin W; Zhao Y; Ji YJ; Tong LP; Liu Y; He SX; Wang AQ Biomed Res Int; 2015; 2015():965185. PubMed ID: 25688372 [TBL] [Abstract][Full Text] [Related]
19. Microarray Expression Profiling of microRNAs Reveals Potential Biomarkers for Hepatocellular Carcinoma. Zhu HR; Huang RZ; Yu XN; Shi X; Bilegsaikhan E; Guo HY; Song GQ; Weng SQ; Dong L; Janssen HLA; Shen XZ; Zhu JM Tohoku J Exp Med; 2018 Jun; 245(2):89-98. PubMed ID: 29899182 [TBL] [Abstract][Full Text] [Related]
20. Biomarker MicroRNAs for Diagnosis, Prognosis and Treatment of Hepatocellular Carcinoma: A Functional Survey and Comparison. Shen S; Lin Y; Yuan X; Shen L; Chen J; Chen L; Qin L; Shen B Sci Rep; 2016 Dec; 6():38311. PubMed ID: 27917899 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]